Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Orthocell Ltd

OCC.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Advanced Medical Equipment & Technology ·

Australia Micro Cap Analyst: BUY

Last Close

$0.55

▼ -2.53%

Market Cap $147.92M · Vol 158.94K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$147.92M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

64.29

Momentum

Beta

0.31

vs Market

52W High

$1.13

48.33% below

52W Low

$0.50

12.58% above

Volume

158.94K

Avg 311.93K

P/B

19.63

Price-to-book

ROE

N/A

Return on equity

Free Float

83.40%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Orthocell Ltd (OCC.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does OCC.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.48%

-3.14%

-7.23%

-16.30%

YTD

-29.03%

-38.89%

+119.43%

+45.28%

Financials & Valuation

TTM · Annual

Total Revenue	$6.07M
Net Income	$-5,636,837.00
Revenue Growth (YoY)	+24.31%
Gross Margin	70.24%
Operating Margin	-127.36%
Net Profit Margin	-92.84%
ROE	N/A
ROA · ROIC	-38.00% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	28.43
P/B	19.63
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	272.33M

Technical Indicators

50-Day SMA	$0.53
200-Day SMA	$0.63
RSI (14)	64.29
Beta	0.31
52-Week High	$1.13
52-Week Low	$0.50

Volume Today	158.94K
Avg Daily Volume (30D)	311.93K
Relative Volume	0.51x
Volatility (10D)	53.93
Volatility (30D)	52.92
Free Float	83.40%

Analyst Consensus

BUY

Current Price $0.55

Mean Target $0.85

52W Low$0.50 52W High$1.13

Current

Target

$0.50 $1.13

Current Analyst target

+55.38% upside potential · 2 analysts

Identifiers

ExchangeASX

FIGIBBG006N6HL66

ISINAU000000OCC6

CountryAustralia

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateAug 27, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is an acellular resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen-based nerve wrap designed to support nerve repair surgery in peripheral nerve repair. OrthoACI, or Autologous Chondrocyte Implantation, offers treatment for symptomatic defects of the articulating cartilage of the joints. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.